Glišić, Teodora

Link to this page

Authority KeyName Variants
orcid::0000-0002-7657-7346
  • Glišić, Teodora (12)
Projects

Author's Bibliography

Ispitivanje sposobnosti kvašenja tečno-čvrstih sistema sa različitim nosačima

Glišić, Teodora; Vasiljević, Ivana; Parojčić, Jelena; Aleksić, Ivana

(Farmaceutska komora Crne Gore, 2023)

TY  - CONF
AU  - Glišić, Teodora
AU  - Vasiljević, Ivana
AU  - Parojčić, Jelena
AU  - Aleksić, Ivana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5337
AB  - Raspadanje tableta u gastrointestinalnim tečnostima i posledično rastvaranje lekovite supstance u korelaciji su sa kvašenjem i prodiranjem vode u tabletu, što je najčešće povezano sa fizičko-hemijskim osobinama ekscipijenasa. Pokazalo se da tečna faza prisutna u tečno-čvrstim (TČ) sistemima poboljšava njihovo kvašenje i posledično povećava bioraspoloživost. Cilj ovog rada bio je da se ispita sposobnost kvašenja TČ sistema pripremljenih sa četiri porozna nosača, korišćenjem različitih metoda ispitivanja. ..
AB  - Tablet disintegration in gastrointestinal fluids and subsequent drug dissolution correlate with
wettability and water penetration into the tablet which are usually related to the physicochemical
properties of excipients. Liquid phase present within Liquisolid (LS) system was shown to
improve wettability and consequently increase bioavailability. The aim of this study was to
examine the wetting properties of LS systems prepared with four porous carriers, by using
different testing methods. ...
PB  - Farmaceutska komora Crne Gore
PB  - Univerzitet Crne Gore, Medicinski fakultet, studijski program-farmacija
C3  - 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023. Budva, Bečići, Crna Gora, Zbornik sažetaka
T1  - Ispitivanje sposobnosti kvašenja tečno-čvrstih sistema sa različitim nosačima
T1  - An investigation into the wetting properties of liquisolid systems with different carriers
VL  - PP-30
SP  - 140
EP  - 141
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5337
ER  - 
@conference{
author = "Glišić, Teodora and Vasiljević, Ivana and Parojčić, Jelena and Aleksić, Ivana",
year = "2023",
abstract = "Raspadanje tableta u gastrointestinalnim tečnostima i posledično rastvaranje lekovite supstance u korelaciji su sa kvašenjem i prodiranjem vode u tabletu, što je najčešće povezano sa fizičko-hemijskim osobinama ekscipijenasa. Pokazalo se da tečna faza prisutna u tečno-čvrstim (TČ) sistemima poboljšava njihovo kvašenje i posledično povećava bioraspoloživost. Cilj ovog rada bio je da se ispita sposobnost kvašenja TČ sistema pripremljenih sa četiri porozna nosača, korišćenjem različitih metoda ispitivanja. .., Tablet disintegration in gastrointestinal fluids and subsequent drug dissolution correlate with
wettability and water penetration into the tablet which are usually related to the physicochemical
properties of excipients. Liquid phase present within Liquisolid (LS) system was shown to
improve wettability and consequently increase bioavailability. The aim of this study was to
examine the wetting properties of LS systems prepared with four porous carriers, by using
different testing methods. ...",
publisher = "Farmaceutska komora Crne Gore, Univerzitet Crne Gore, Medicinski fakultet, studijski program-farmacija",
journal = "4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023. Budva, Bečići, Crna Gora, Zbornik sažetaka",
title = "Ispitivanje sposobnosti kvašenja tečno-čvrstih sistema sa različitim nosačima, An investigation into the wetting properties of liquisolid systems with different carriers",
volume = "PP-30",
pages = "140-141",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5337"
}
Glišić, T., Vasiljević, I., Parojčić, J.,& Aleksić, I.. (2023). Ispitivanje sposobnosti kvašenja tečno-čvrstih sistema sa različitim nosačima. in 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023. Budva, Bečići, Crna Gora, Zbornik sažetaka
Farmaceutska komora Crne Gore., PP-30, 140-141.
https://hdl.handle.net/21.15107/rcub_farfar_5337
Glišić T, Vasiljević I, Parojčić J, Aleksić I. Ispitivanje sposobnosti kvašenja tečno-čvrstih sistema sa različitim nosačima. in 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023. Budva, Bečići, Crna Gora, Zbornik sažetaka. 2023;PP-30:140-141.
https://hdl.handle.net/21.15107/rcub_farfar_5337 .
Glišić, Teodora, Vasiljević, Ivana, Parojčić, Jelena, Aleksić, Ivana, "Ispitivanje sposobnosti kvašenja tečno-čvrstih sistema sa različitim nosačima" in 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023. Budva, Bečići, Crna Gora, Zbornik sažetaka, PP-30 (2023):140-141,
https://hdl.handle.net/21.15107/rcub_farfar_5337 .

Formulacija i karakterizacija mini tableta desloratadina dobijenih fotopolimerizacionom tehnikom 3D štampe lekova

Adamov, Ivana; Glišić, Teodora; Medarević, Đorđe; Aleksić, Ivana; Ibrić, Svetlana

(Savez farmaceutskih udruženja Srbije, 2023)

TY  - CONF
AU  - Adamov, Ivana
AU  - Glišić, Teodora
AU  - Medarević, Đorđe
AU  - Aleksić, Ivana
AU  - Ibrić, Svetlana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5331
AB  - 3D štampa lekova, kao aditivna tehnologija, predstavlja jednostavnu i ekonomski prihvatljivu
alternativu konvencionalnim metodama, pružajući mogućnost dobijanja inovativnih farmaceutskih
oblika i prilagođavanje terapije individualnim potrebama pacijenata (1). Cilj istraživanja bio je da se
formulišu i izrade mini tablete desloratadinа (DSL) primenom 3D tehnike digitalne obrade svetlosti
(engl. Digital light processing, DLP) mehanizmom nanošenja materijala “sloj po sloj”. Mini tablete DSL
(10%, m/m) odabrane su kao farmaceutski oblik leka koji je pogodan za primenu u pedijatrijskoj
populaciji, pre svega sa aspekta fleksibilnosti doziranja. Pripremljena je formulacija sa 1%
fotoinicijatora i 10% vode, dok su polietilenglikol-diakrilat i polietilenglikol 400 bili prisutni u
masenom odnosu 1:1. Kreirani 3D modeli (4,00 × 3,00 mm) uspešno su odštampani primenom
WanhaoD8 štampača. Dobijene su žuto-narandžaste mini tablete uniformnog oblika, debljine i mase
(4,16 ± 0,06 × 2,24 ± 0,04 mm; 42,61 ± 1,15 mg). Nepotpuna ekstrakcija DSL iz unakrsno umreženog
polimernog matriksa rezultovala je relativno niskim sadržajem lekovite supstance u mini tabletama
u odnosu na teorijski sadržaj (72,14 ± 1,04%) (2). Prilikom ispitivanja brzine rastvaranja, nakon 45
min oslobođeno je 50,29 ± 0,14% DSL u 0,1M hlorovodoničnoj kiselini, kao medijumu, uz postizanje
platoa nakon 4 sata (81,19 ± 0,63%). Rezultati DSC analize pokazali su da je došlo do amorfizacije
lekovite supstance, dok je posmatranjem poprečnih preseka odštampanih mini tableta pod
polarizacionim svetlosnim mikroskopom uočeno prisustvo slojevite strukture. DLP tehnika 3D
štampe lekova ima potencijal da obezbedi brzu izradu mini tableta odgovarajućih fizičko-hemijskih
karakteristika, uz mogućnost postizanja modifikovanog oslobađanja lekovite supstance.
AB  - 3D printing as an additive technology represents a simple and economically acceptable
alternative to conventional methods and offers the possibility of obtaining innovative dosage forms
and individualizing therapy according to the specific needs of patients. (1). The aim of the research
was to formulate and manufacture desloratadine mini-tablets (DSL) using digital light processing
(DLP) 3D technique based on a successive layering mechanism. Mini-tablets of DSL (10%,w/w) were
selected as a dosage form suitable for the pediatric population, particularly because of its flexible
dosing. The formulation was prepared with 1% photoinitiator and 10% water, while poly(ethylene
glycol) diacrylate and poly(ethylene glycol) 400 were present in a mass ratio of 1:1. The created 3D
models (4.00×3.00 mm) were successfully printed using WanhaoD8 printer. Yellow-orange mini-
tablets with uniform shape, thickness and mass (4.16±0.06×2.24±0.04 mm; 42.61±1.15 mg) were
produced. Incomplete extraction of DSL from the cross-linked polymer matrix resulted in a relatively
low content of the drug in the mini-tablets compared to the theoretical content (72.14±1.04%) (2).
The dissolution test showed that 50.29±0.14% of DSL was released after 45 minutes in 0.1M
hydrochloric acid medium and reached a plateau after 4 hours (81.19±0.63%). The results of DSC
analysis showed amorphisation of the drug, while observation of the cross-sections of printed mini-
tablets under a polarizing microscope indicated the presence of a layered structure. The DLP
technique has the potential to ensure the rapid production of mini-tablets with suitable
physicochemical properties and to enable modified release of the drug.
PB  - Savez farmaceutskih udruženja Srbije
C3  - Arhiv za farmaciju
T1  - Formulacija i karakterizacija mini tableta desloratadina dobijenih  fotopolimerizacionom tehnikom 3D štampe lekova
T1  - Formulation and characterization of desloratadine mini-tablets obtained by photopolimerization 3D printing technique
VL  - 73
IS  - Suppl. 4
SP  - S59
EP  - S60
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5331
ER  - 
@conference{
author = "Adamov, Ivana and Glišić, Teodora and Medarević, Đorđe and Aleksić, Ivana and Ibrić, Svetlana",
year = "2023",
abstract = "3D štampa lekova, kao aditivna tehnologija, predstavlja jednostavnu i ekonomski prihvatljivu
alternativu konvencionalnim metodama, pružajući mogućnost dobijanja inovativnih farmaceutskih
oblika i prilagođavanje terapije individualnim potrebama pacijenata (1). Cilj istraživanja bio je da se
formulišu i izrade mini tablete desloratadinа (DSL) primenom 3D tehnike digitalne obrade svetlosti
(engl. Digital light processing, DLP) mehanizmom nanošenja materijala “sloj po sloj”. Mini tablete DSL
(10%, m/m) odabrane su kao farmaceutski oblik leka koji je pogodan za primenu u pedijatrijskoj
populaciji, pre svega sa aspekta fleksibilnosti doziranja. Pripremljena je formulacija sa 1%
fotoinicijatora i 10% vode, dok su polietilenglikol-diakrilat i polietilenglikol 400 bili prisutni u
masenom odnosu 1:1. Kreirani 3D modeli (4,00 × 3,00 mm) uspešno su odštampani primenom
WanhaoD8 štampača. Dobijene su žuto-narandžaste mini tablete uniformnog oblika, debljine i mase
(4,16 ± 0,06 × 2,24 ± 0,04 mm; 42,61 ± 1,15 mg). Nepotpuna ekstrakcija DSL iz unakrsno umreženog
polimernog matriksa rezultovala je relativno niskim sadržajem lekovite supstance u mini tabletama
u odnosu na teorijski sadržaj (72,14 ± 1,04%) (2). Prilikom ispitivanja brzine rastvaranja, nakon 45
min oslobođeno je 50,29 ± 0,14% DSL u 0,1M hlorovodoničnoj kiselini, kao medijumu, uz postizanje
platoa nakon 4 sata (81,19 ± 0,63%). Rezultati DSC analize pokazali su da je došlo do amorfizacije
lekovite supstance, dok je posmatranjem poprečnih preseka odštampanih mini tableta pod
polarizacionim svetlosnim mikroskopom uočeno prisustvo slojevite strukture. DLP tehnika 3D
štampe lekova ima potencijal da obezbedi brzu izradu mini tableta odgovarajućih fizičko-hemijskih
karakteristika, uz mogućnost postizanja modifikovanog oslobađanja lekovite supstance., 3D printing as an additive technology represents a simple and economically acceptable
alternative to conventional methods and offers the possibility of obtaining innovative dosage forms
and individualizing therapy according to the specific needs of patients. (1). The aim of the research
was to formulate and manufacture desloratadine mini-tablets (DSL) using digital light processing
(DLP) 3D technique based on a successive layering mechanism. Mini-tablets of DSL (10%,w/w) were
selected as a dosage form suitable for the pediatric population, particularly because of its flexible
dosing. The formulation was prepared with 1% photoinitiator and 10% water, while poly(ethylene
glycol) diacrylate and poly(ethylene glycol) 400 were present in a mass ratio of 1:1. The created 3D
models (4.00×3.00 mm) were successfully printed using WanhaoD8 printer. Yellow-orange mini-
tablets with uniform shape, thickness and mass (4.16±0.06×2.24±0.04 mm; 42.61±1.15 mg) were
produced. Incomplete extraction of DSL from the cross-linked polymer matrix resulted in a relatively
low content of the drug in the mini-tablets compared to the theoretical content (72.14±1.04%) (2).
The dissolution test showed that 50.29±0.14% of DSL was released after 45 minutes in 0.1M
hydrochloric acid medium and reached a plateau after 4 hours (81.19±0.63%). The results of DSC
analysis showed amorphisation of the drug, while observation of the cross-sections of printed mini-
tablets under a polarizing microscope indicated the presence of a layered structure. The DLP
technique has the potential to ensure the rapid production of mini-tablets with suitable
physicochemical properties and to enable modified release of the drug.",
publisher = "Savez farmaceutskih udruženja Srbije",
journal = "Arhiv za farmaciju",
title = "Formulacija i karakterizacija mini tableta desloratadina dobijenih  fotopolimerizacionom tehnikom 3D štampe lekova, Formulation and characterization of desloratadine mini-tablets obtained by photopolimerization 3D printing technique",
volume = "73",
number = "Suppl. 4",
pages = "S59-S60",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5331"
}
Adamov, I., Glišić, T., Medarević, Đ., Aleksić, I.,& Ibrić, S.. (2023). Formulacija i karakterizacija mini tableta desloratadina dobijenih  fotopolimerizacionom tehnikom 3D štampe lekova. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije., 73(Suppl. 4), S59-S60.
https://hdl.handle.net/21.15107/rcub_farfar_5331
Adamov I, Glišić T, Medarević Đ, Aleksić I, Ibrić S. Formulacija i karakterizacija mini tableta desloratadina dobijenih  fotopolimerizacionom tehnikom 3D štampe lekova. in Arhiv za farmaciju. 2023;73(Suppl. 4):S59-S60.
https://hdl.handle.net/21.15107/rcub_farfar_5331 .
Adamov, Ivana, Glišić, Teodora, Medarević, Đorđe, Aleksić, Ivana, Ibrić, Svetlana, "Formulacija i karakterizacija mini tableta desloratadina dobijenih  fotopolimerizacionom tehnikom 3D štampe lekova" in Arhiv za farmaciju, 73, no. Suppl. 4 (2023):S59-S60,
https://hdl.handle.net/21.15107/rcub_farfar_5331 .

From co-processing by melt granulation towards direct compression of high ibuprofen loaded formulations

Aleksić, Ivana; Ćirin-Varađan, Slobodanka; Glišić, Teodora; Petrović, Nađa; Đuriš, Jelena; Parojčić, Jelena

(Macedonian Pharmaceutical Association, 2023)

TY  - CONF
AU  - Aleksić, Ivana
AU  - Ćirin-Varađan, Slobodanka
AU  - Glišić, Teodora
AU  - Petrović, Nađa
AU  - Đuriš, Jelena
AU  - Parojčić, Jelena
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5067
AB  - Direct compression, as the simplest and therefore
preferable method of tableting, is often hindered by poor
flow and compaction properties of the active
pharmaceutical ingredient (API). Tableting by direct
compression is particularly challenging when high API
loading is required. The use of co-processed excipients can
result in a robust directly compressible formulation, while
melt granulation has emerged as an environmentally
friendly co-processing method that can result in highly
functional co-processed excipients (Ćirin-Varađan et al,
2022).
The aim of the present study was to investigate the
suitability of lactose co-processed with glyceryl
palmitostearate for the preparation of a directly
compressible formulation of ibuprofen, a challenging high-
dose API. The influence of initial particle size of glyceryl
palmitostearate, ibuprofen content and compression
parameters on compaction behavior of tableting mixtures
was investigated.
PB  - Macedonian Pharmaceutical Association
PB  - Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
C3  - Macedonian Pharmaceutical Bulletin
T1  - From co-processing by melt granulation towards direct compression of high ibuprofen loaded formulations
VL  - 69
IS  - Suppl 1
SP  - 139
EP  - 140
DO  - 10.33320/maced.pharm.bull.2023.69.03.068
ER  - 
@conference{
author = "Aleksić, Ivana and Ćirin-Varađan, Slobodanka and Glišić, Teodora and Petrović, Nađa and Đuriš, Jelena and Parojčić, Jelena",
year = "2023",
abstract = "Direct compression, as the simplest and therefore
preferable method of tableting, is often hindered by poor
flow and compaction properties of the active
pharmaceutical ingredient (API). Tableting by direct
compression is particularly challenging when high API
loading is required. The use of co-processed excipients can
result in a robust directly compressible formulation, while
melt granulation has emerged as an environmentally
friendly co-processing method that can result in highly
functional co-processed excipients (Ćirin-Varađan et al,
2022).
The aim of the present study was to investigate the
suitability of lactose co-processed with glyceryl
palmitostearate for the preparation of a directly
compressible formulation of ibuprofen, a challenging high-
dose API. The influence of initial particle size of glyceryl
palmitostearate, ibuprofen content and compression
parameters on compaction behavior of tableting mixtures
was investigated.",
publisher = "Macedonian Pharmaceutical Association, Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy",
journal = "Macedonian Pharmaceutical Bulletin",
title = "From co-processing by melt granulation towards direct compression of high ibuprofen loaded formulations",
volume = "69",
number = "Suppl 1",
pages = "139-140",
doi = "10.33320/maced.pharm.bull.2023.69.03.068"
}
Aleksić, I., Ćirin-Varađan, S., Glišić, T., Petrović, N., Đuriš, J.,& Parojčić, J.. (2023). From co-processing by melt granulation towards direct compression of high ibuprofen loaded formulations. in Macedonian Pharmaceutical Bulletin
Macedonian Pharmaceutical Association., 69(Suppl 1), 139-140.
https://doi.org/10.33320/maced.pharm.bull.2023.69.03.068
Aleksić I, Ćirin-Varađan S, Glišić T, Petrović N, Đuriš J, Parojčić J. From co-processing by melt granulation towards direct compression of high ibuprofen loaded formulations. in Macedonian Pharmaceutical Bulletin. 2023;69(Suppl 1):139-140.
doi:10.33320/maced.pharm.bull.2023.69.03.068 .
Aleksić, Ivana, Ćirin-Varađan, Slobodanka, Glišić, Teodora, Petrović, Nađa, Đuriš, Jelena, Parojčić, Jelena, "From co-processing by melt granulation towards direct compression of high ibuprofen loaded formulations" in Macedonian Pharmaceutical Bulletin, 69, no. Suppl 1 (2023):139-140,
https://doi.org/10.33320/maced.pharm.bull.2023.69.03.068 . .

Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers

Glišić, Teodora; Đuriš, Jelena; Vasiljević, Ivana; Parojčić, Jelena; Aleksić, Ivana

(MDPI, 2023)

TY  - JOUR
AU  - Glišić, Teodora
AU  - Đuriš, Jelena
AU  - Vasiljević, Ivana
AU  - Parojčić, Jelena
AU  - Aleksić, Ivana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4581
AB  - The processing of liquisolid systems (LSS), which are considered a promising approach
to improving the oral bioavailability of poorly soluble drugs, has proven challenging due to the
relatively high amount of liquid phase incorporated within them. The objective of this study was to
apply machine-learning tools to better understand the effects of formulation factors and/or tableting
process parameters on the flowability and compaction properties of LSS with silica-based mesoporous
excipients as carriers. In addition, the results of the flowability testing and dynamic compaction
analysis of liquisolid admixtures were used to build data sets and develop predictive multivariate
models. In the regression analysis, six different algorithms were used to model the relationship
between tensile strength (TS), the target variable, and eight other input variables. The AdaBoost
algorithm provided the best-fit model for predicting TS (coefficient of determination = 0.94), with
ejection stress (ES), compaction pressure, and carrier type being the parameters that influenced its
performance the most. The same algorithm was best for classification (precision = 0.90), depending on
the type of carrier used, with detachment stress, ES, and TS as variables affecting the performance of
the model. Furthermore, the formulations with Neusilin® US2 were able to maintain good flowability
and satisfactory values of TS despite having a higher liquid load compared to the other two carriers.
PB  - MDPI
T2  - Pharmaceutics
T1  - Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers
VL  - 15
IS  - 3
SP  - 741
EP  - 761
DO  - 10.3390/pharmaceutics15030741
ER  - 
@article{
author = "Glišić, Teodora and Đuriš, Jelena and Vasiljević, Ivana and Parojčić, Jelena and Aleksić, Ivana",
year = "2023",
abstract = "The processing of liquisolid systems (LSS), which are considered a promising approach
to improving the oral bioavailability of poorly soluble drugs, has proven challenging due to the
relatively high amount of liquid phase incorporated within them. The objective of this study was to
apply machine-learning tools to better understand the effects of formulation factors and/or tableting
process parameters on the flowability and compaction properties of LSS with silica-based mesoporous
excipients as carriers. In addition, the results of the flowability testing and dynamic compaction
analysis of liquisolid admixtures were used to build data sets and develop predictive multivariate
models. In the regression analysis, six different algorithms were used to model the relationship
between tensile strength (TS), the target variable, and eight other input variables. The AdaBoost
algorithm provided the best-fit model for predicting TS (coefficient of determination = 0.94), with
ejection stress (ES), compaction pressure, and carrier type being the parameters that influenced its
performance the most. The same algorithm was best for classification (precision = 0.90), depending on
the type of carrier used, with detachment stress, ES, and TS as variables affecting the performance of
the model. Furthermore, the formulations with Neusilin® US2 were able to maintain good flowability
and satisfactory values of TS despite having a higher liquid load compared to the other two carriers.",
publisher = "MDPI",
journal = "Pharmaceutics",
title = "Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers",
volume = "15",
number = "3",
pages = "741-761",
doi = "10.3390/pharmaceutics15030741"
}
Glišić, T., Đuriš, J., Vasiljević, I., Parojčić, J.,& Aleksić, I.. (2023). Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers. in Pharmaceutics
MDPI., 15(3), 741-761.
https://doi.org/10.3390/pharmaceutics15030741
Glišić T, Đuriš J, Vasiljević I, Parojčić J, Aleksić I. Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers. in Pharmaceutics. 2023;15(3):741-761.
doi:10.3390/pharmaceutics15030741 .
Glišić, Teodora, Đuriš, Jelena, Vasiljević, Ivana, Parojčić, Jelena, Aleksić, Ivana, "Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers" in Pharmaceutics, 15, no. 3 (2023):741-761,
https://doi.org/10.3390/pharmaceutics15030741 . .

Comparative compression characterization of liquisolid systems prepared with mesoporous carriers

Glišić, Teodora; German Ilić, Ilija; Parojčić, Jelena; Aleksić, Ivana

(Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo, 2022)

TY  - CONF
AU  - Glišić, Teodora
AU  - German Ilić, Ilija
AU  - Parojčić, Jelena
AU  - Aleksić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4750
AB  - 1. INTRODUCTION
Maintaining good compaction properties of
liquisolid systems (LSS) is particularly
challenging in the case of high-dose drugs [1].
High amount of liquid phase within LSS,
required to dissolve/suspend higher amount of
drug substance, while necessary for
improvement of bioavailability, can cause
difficulties during the tableting process,
resulting in low tablet hardness or even inability
of admixtures to be directly compressed. This
has led to the development of new highly porous
carriers, specifically designed for LSS, that can
adsorb/absorb very high amount of liquid phase.
The aim of this study was to investigate the
compaction properties of LSS, prepared with
three types of novel silica-based mesoporous
carriers, using dynamic compaction analysis as
a tool, with the focus on compressibility,
compactibility and tabletability of these systems
[2].
2. MATERIALS AND METHODS
2.1. Materials
Amorphous magnesium aluminometasilicate
(Neusilin® US2, Fuji Chemical Industry Co,
Ltd., Japan) and two types of amorphous
mesoporous silicon dioxide (Syloid® XDP 3050
and Syloid® XDP 3150, Grace GmbH,
Germany) were used as carriers. Colloidal
silicon dioxide (Aerosil 200, Evonik Industries
AG, Germany) was used as coating material and
polyethylene glycol 400 (PEG 400, Fagron,
Netherlands) was used as liquid phase.
2.2. Liquisolid Admixture Preparation
LS admixtures (Table 1) were prepared using
Mycrolab fluid bed processor (OYSTAR
Hüttlin, Germany), with the operating
temperature of 30°C, inlet air flow rate of 20
m3/h, and liquid feed rate of 12 g/min.
Table 1. Composition of prepared LS
admixtures
Liquisolid
admixturesa Rb Liquid
load
PEG
400 (%)
S1 10 0.7 38.9
S2 30 0.7 40.4
S3 10 0.6 35.3
S4 30 0.6 36.7
N1 10 1.1 49.8
N2 30 1.2 54.7
a type of carrier used: S1, S2 - Syloid® XDP
3050, S3, S4 - Syloid® XDP 3150, N1, N2 -
Neusilin® US2; bcarrier to coating material ratio
2.3. Powder density
LS admixtures’ true densities were determined
by helium pycnometer (AccuPyc 1330,
Micromeritics, GA) while bulk and tapped
densities were measured using a graduated
cylinder and a volumeter (STAV 2003, J.
Engelsmann AG, Germany).
2.4. Powder morphology
The morphology of LS particles was examined
using a scanning electron microscope (SEM,
Supra 35VP, Carl Zeiss, Germany).
2.5. Dynamic compaction analysis
Dynamic compaction analysis was performed
on an instrumented tablet press (GTP D series,
Gamlen Tableting Ltd, UK). 6 mm flat faced
punches were used at a compaction speed of 60
mm/min, with compression load ranging from
250 to 500 kg, with a 50 kg increment.
3. RESULTS AND DISCUSSION
3.1. Compressibility of LS admixtures
Regardless of the compaction pressure applied
and differences in liquid load, very high values
of solid fraction were observed in LS compacts
with Neusilin® US2 (0.90-0.94). On the other
hand, LS compacts with both Syloid® XDP
carriers exhibited lower relative density (0.59-
0.89) that was affected by changes in the
applied compaction pressure. Compressibility
profiles suggest that carrier particle size and the
amount of coating material used, had an effect
on relative density. An increase in the amount
of coating material used had a negative impact
on compressibility and lower values of solid
fraction were achieved.
3.2. Compactibility of LS admixtures
Admixtures N1 and N2 could be considered as
having good compactibility [3]. Compacts with
Neusilin® US2 achieved higher tensile strength
values compared to compacts with Syloid®
XDP, even at low compaction pressures.
Particle geometry and shape (Fig. 1) can affect
the way particles interact during tableting and
therefore may affect their mechanical
characteristics. Differences in particle size
could be a reason for lower values of solid
fraction and tensile strength observed in
compacts prepared with Syloid® XDP 3150
compared to compacts with Syloid® XDP 3050
as carrier.
Figure 1. SEM micrographies of LS particles:
admixture N1 (left) and S1 (right)
3.3. Tabletability of LS admixtures
Despite the significantly higher liquid load,
better tabletability was observed in LSS with
Neusilin® US2 as carrier with tensile strength
ranging from 1,68 to 2,55 and 1,61 to 2,11 for
formulations N1 and N2, respectively.
Although relatively similar values of tensile
strength were achieved, tabletability profiles
indicate that there are differences in compaction
behavior between formulations N1 and N2.
Higher values of tensile strength observed at the
same compression pressure indicate better
tabletability of LS admixtures with Syloid®
XDP 3050 compared to those with Syloid®
XDP 3150 as carrier. Interestingly,
formulations with Syloid® XDP 3050 had
higher liquid load which implies that this
formulation factor had lesser influence on
tabletability compared to the properties of the
carrier itself (such as particle size and specific
surface area). The lowest tabletability was
observed in LS admixtures S3 and S4 with
compact tensile strength lower than 1 MPa at all
but highest compaction pressure applied.
4. CONCLUSION
Out of the three investigated carriers, Neusilin®
US2 showed the best compaction properties
despite its high liquid load. LS admixtures with
this carrier exhibited the highest values of
tensile strength and solid fraction at relatively
low compression pressures. Pronounced
differences have been noticed between the two
Syloid carriers, which indicates the effect of
carrier particle size on compaction properties of
LS admixtures.
PB  - Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo
C3  - 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts
T1  - Comparative compression characterization of liquisolid systems prepared with mesoporous carriers
SP  - 180
EP  - 181
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4750
ER  - 
@conference{
author = "Glišić, Teodora and German Ilić, Ilija and Parojčić, Jelena and Aleksić, Ivana",
year = "2022",
abstract = "1. INTRODUCTION
Maintaining good compaction properties of
liquisolid systems (LSS) is particularly
challenging in the case of high-dose drugs [1].
High amount of liquid phase within LSS,
required to dissolve/suspend higher amount of
drug substance, while necessary for
improvement of bioavailability, can cause
difficulties during the tableting process,
resulting in low tablet hardness or even inability
of admixtures to be directly compressed. This
has led to the development of new highly porous
carriers, specifically designed for LSS, that can
adsorb/absorb very high amount of liquid phase.
The aim of this study was to investigate the
compaction properties of LSS, prepared with
three types of novel silica-based mesoporous
carriers, using dynamic compaction analysis as
a tool, with the focus on compressibility,
compactibility and tabletability of these systems
[2].
2. MATERIALS AND METHODS
2.1. Materials
Amorphous magnesium aluminometasilicate
(Neusilin® US2, Fuji Chemical Industry Co,
Ltd., Japan) and two types of amorphous
mesoporous silicon dioxide (Syloid® XDP 3050
and Syloid® XDP 3150, Grace GmbH,
Germany) were used as carriers. Colloidal
silicon dioxide (Aerosil 200, Evonik Industries
AG, Germany) was used as coating material and
polyethylene glycol 400 (PEG 400, Fagron,
Netherlands) was used as liquid phase.
2.2. Liquisolid Admixture Preparation
LS admixtures (Table 1) were prepared using
Mycrolab fluid bed processor (OYSTAR
Hüttlin, Germany), with the operating
temperature of 30°C, inlet air flow rate of 20
m3/h, and liquid feed rate of 12 g/min.
Table 1. Composition of prepared LS
admixtures
Liquisolid
admixturesa Rb Liquid
load
PEG
400 (%)
S1 10 0.7 38.9
S2 30 0.7 40.4
S3 10 0.6 35.3
S4 30 0.6 36.7
N1 10 1.1 49.8
N2 30 1.2 54.7
a type of carrier used: S1, S2 - Syloid® XDP
3050, S3, S4 - Syloid® XDP 3150, N1, N2 -
Neusilin® US2; bcarrier to coating material ratio
2.3. Powder density
LS admixtures’ true densities were determined
by helium pycnometer (AccuPyc 1330,
Micromeritics, GA) while bulk and tapped
densities were measured using a graduated
cylinder and a volumeter (STAV 2003, J.
Engelsmann AG, Germany).
2.4. Powder morphology
The morphology of LS particles was examined
using a scanning electron microscope (SEM,
Supra 35VP, Carl Zeiss, Germany).
2.5. Dynamic compaction analysis
Dynamic compaction analysis was performed
on an instrumented tablet press (GTP D series,
Gamlen Tableting Ltd, UK). 6 mm flat faced
punches were used at a compaction speed of 60
mm/min, with compression load ranging from
250 to 500 kg, with a 50 kg increment.
3. RESULTS AND DISCUSSION
3.1. Compressibility of LS admixtures
Regardless of the compaction pressure applied
and differences in liquid load, very high values
of solid fraction were observed in LS compacts
with Neusilin® US2 (0.90-0.94). On the other
hand, LS compacts with both Syloid® XDP
carriers exhibited lower relative density (0.59-
0.89) that was affected by changes in the
applied compaction pressure. Compressibility
profiles suggest that carrier particle size and the
amount of coating material used, had an effect
on relative density. An increase in the amount
of coating material used had a negative impact
on compressibility and lower values of solid
fraction were achieved.
3.2. Compactibility of LS admixtures
Admixtures N1 and N2 could be considered as
having good compactibility [3]. Compacts with
Neusilin® US2 achieved higher tensile strength
values compared to compacts with Syloid®
XDP, even at low compaction pressures.
Particle geometry and shape (Fig. 1) can affect
the way particles interact during tableting and
therefore may affect their mechanical
characteristics. Differences in particle size
could be a reason for lower values of solid
fraction and tensile strength observed in
compacts prepared with Syloid® XDP 3150
compared to compacts with Syloid® XDP 3050
as carrier.
Figure 1. SEM micrographies of LS particles:
admixture N1 (left) and S1 (right)
3.3. Tabletability of LS admixtures
Despite the significantly higher liquid load,
better tabletability was observed in LSS with
Neusilin® US2 as carrier with tensile strength
ranging from 1,68 to 2,55 and 1,61 to 2,11 for
formulations N1 and N2, respectively.
Although relatively similar values of tensile
strength were achieved, tabletability profiles
indicate that there are differences in compaction
behavior between formulations N1 and N2.
Higher values of tensile strength observed at the
same compression pressure indicate better
tabletability of LS admixtures with Syloid®
XDP 3050 compared to those with Syloid®
XDP 3150 as carrier. Interestingly,
formulations with Syloid® XDP 3050 had
higher liquid load which implies that this
formulation factor had lesser influence on
tabletability compared to the properties of the
carrier itself (such as particle size and specific
surface area). The lowest tabletability was
observed in LS admixtures S3 and S4 with
compact tensile strength lower than 1 MPa at all
but highest compaction pressure applied.
4. CONCLUSION
Out of the three investigated carriers, Neusilin®
US2 showed the best compaction properties
despite its high liquid load. LS admixtures with
this carrier exhibited the highest values of
tensile strength and solid fraction at relatively
low compression pressures. Pronounced
differences have been noticed between the two
Syloid carriers, which indicates the effect of
carrier particle size on compaction properties of
LS admixtures.",
publisher = "Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo",
journal = "9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts",
title = "Comparative compression characterization of liquisolid systems prepared with mesoporous carriers",
pages = "180-181",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4750"
}
Glišić, T., German Ilić, I., Parojčić, J.,& Aleksić, I.. (2022). Comparative compression characterization of liquisolid systems prepared with mesoporous carriers. in 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts
Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo., 180-181.
https://hdl.handle.net/21.15107/rcub_farfar_4750
Glišić T, German Ilić I, Parojčić J, Aleksić I. Comparative compression characterization of liquisolid systems prepared with mesoporous carriers. in 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts. 2022;:180-181.
https://hdl.handle.net/21.15107/rcub_farfar_4750 .
Glišić, Teodora, German Ilić, Ilija, Parojčić, Jelena, Aleksić, Ivana, "Comparative compression characterization of liquisolid systems prepared with mesoporous carriers" in 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts (2022):180-181,
https://hdl.handle.net/21.15107/rcub_farfar_4750 .

Evaluation of dilution capacity and compaction behaviour of the excipients co-processed by in situ fluidized bed melt granulation

Aleksić, Ivana; Ćirin-Varađan, Slobodanka; Glišić, Teodora; Đuriš, Mihal; Đuriš, Jelena; Parojčić, Jelena

(Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo, 2022)

TY  - CONF
AU  - Aleksić, Ivana
AU  - Ćirin-Varađan, Slobodanka
AU  - Glišić, Teodora
AU  - Đuriš, Mihal
AU  - Đuriš, Jelena
AU  - Parojčić, Jelena
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4735
AB  - 1. INTRODUCTION
Co-processing has emerged as a suitable
approach to meet the increasing demands for
excipients with improved tableting
performance. Apart from the most commonly
used energy-consuming co-processing methods
(e.g. spray-drying and wet granulation), melt
granulation as a solvent-free and more
environmentally friendly technique has recently
gained more attention [1].
The aim of the present study was to investigate
the influence of meltable binder particle size
and compaction parameters on dilution capacity
and compaction behaviour of lactose-based coprocessed
excipients.
2. MATERIALS AND METHODS
2.1. Materials
Paracetamol (Acros Organics, Belgium) was
used as the model drug. Lactose monohydrate
(Carlo Erba Reagents, Italy) was used as filler
and glyceryl palmitostearate (Precirol® ATO 5
Gattefossé S.A.S, France) as meltable binder.
2.2. Preparation of co-processed excipients
Co-processed excipients were prepared by in
situ melt granulation in Mycrolab fluid bed
processor (OYSTAR Hüttlin, Germany).
Precirol® particles (15%) from the 125–180 μm
(≈ 150 μm) or 600–710 μm sieve fraction (≈ 655
μm) were used for granulation of lactose (85%).
The inlet air flow rate was 30 m3/h, and product
temperature during agglomeration was 65 °C.
2.3. Particle size and shape analysis
Granule size distribution was evaluated by sieve
analysis, and median particle diameter (d50) was
calculated by linear interpolation of the
cumulative percentage frequency curve.
Granule shape was examined by 2D scanned
image (4800 dpi resolution) analysis using
ImageJ software. The aspect ratio (AR) and
circularity (C) were calculated for granule shape
evaluation.
2.3. Determination of the Carr index
The bulk and tapped (1250 taps) densities of coprocessed
excipients and their mixtures with 30,
40 or 50% paracetamol were determined using
tap density tester STAV 2003 (J. Engelsmann
AG, Germany), and Carr index was calculated.
2.4. Dynamic compaction analysis
Co-processed excipients and their mixtures with
paracetamol were compressed on a single punch
instrumented tablet press (GTP D series,
Gamlen Tableting Ltd, UK). Compacts (100
mg) were compressed under compression load
of 200 kg (≈ 70 MPa) or 500 kg (≈ 173MPa),
and compression speed of 60 or 120 mm/min. 6
mm flat faced punches were used. The obtained
force-displacement curves were used to
calculate: net work of compression (NW),
detachment stress (DS), ejection stress (ES).
Tablet crushing force was determined using
tablet hardness tester Erweka TBH 125D
(Erweka GmbH, Germany), and the values
obtained were used to calculate tensile strength
(TS). Elastic recovery (24 h after compression)
was calculated, as well.
2.4. Experimental Design
In order to investigate the influence of binder
particle size, paracetamol content and
compression speed on the abovementioned
compaction properties, compacts were
prepared, at compression load of 500 kg,
according to 23 full factorial design.
3. RESULTS AND DISCUSSION
3.1. Particle size and shape
Larger initial binder particle size led to
formation of larger and more spherical granules
(Table 1).
147
Table 1. The size and shape of the co-processed
excipients’ particles.
Binder PS (μm) d50 AR C
150 564.9 1.33 0.81
655 846.2 1.14 0.86
3.2. Flowability
The Carr index values obtained indicated
considerably better flowability of the coprocessed
excipient prepared by using larger
binder particles (P655) in comparison with the
excipient prepared with smaller binder particles
(P150). This might be ascribed to more
spherical and larger particles of P655. However,
the addition of paracetamol led to an increase in
Carr index values and less pronounced
differences between two excipients (Fig. 1).
Figure 1. The influence of paracetamol loading
on flowability of co-processed excipients.
3.3. Compaction behaviour
The results obtained revealed better mechanical
properties of P150 in comparison with P655
compacts, irrespective of the compression
pressure applied. The addition of paracetamol,
as the model API with poor compaction
properties, led to decrease in tensile strength of
the compacts prepared with both excipients, and
paracetamol content showed statistically
significant influence on TS (p < 0.0001).
Acceptable tensile strength (> 1 MPa) could be
achieved for compacts with 30% paracetamol
compressed at higher compression pressure (≈
173 MPa).
Paracetamol content, compression speed and
interaction between binder particle size and
paracetamol content were found to significantly
affect NW. The influence of binder particle size
was more pronounced at higher paracetamol
content, with lower NW observed in the case of
P655. Higher compression speed led to higher
NW.
Relatively low values of detachment and
ejection stress (< 3.5 MPa) indicate good
antiadhesive and lubricating properties of the
investigated excipients. Lower values of both
parameters were observed in the case of P655
which could be related to different
agglomeration mechanisms involved. Besides
binder particle size, compression speed and
paracetamol content were found to significantly
influence these properties.
Elastic recovery values of the investigated
samples ranged between 12 and 28%. In the
case of both excipients, higher elastic recovery
values were obtained at higher compression
pressure. ER values of the compacts prepared at
higher compression pressure were significantly
affected by compression speed and interactions
of the investigated variables.
4. CONCLUSION
The results obtained show that meltable binder
particle size affects granule size and shape, and
consequently may influence flowability and
compaction behaviour of the co-processed
excipients. Interactions between binder particle
size and compaction variables were also found
to affect compaction properties of the
investigated excipients.
PB  - Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo
C3  - 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts
T1  - Evaluation of dilution capacity and compaction behaviour of the excipients co-processed by in situ fluidized bed melt granulation
SP  - 146
EP  - 147
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4735
ER  - 
@conference{
author = "Aleksić, Ivana and Ćirin-Varađan, Slobodanka and Glišić, Teodora and Đuriš, Mihal and Đuriš, Jelena and Parojčić, Jelena",
year = "2022",
abstract = "1. INTRODUCTION
Co-processing has emerged as a suitable
approach to meet the increasing demands for
excipients with improved tableting
performance. Apart from the most commonly
used energy-consuming co-processing methods
(e.g. spray-drying and wet granulation), melt
granulation as a solvent-free and more
environmentally friendly technique has recently
gained more attention [1].
The aim of the present study was to investigate
the influence of meltable binder particle size
and compaction parameters on dilution capacity
and compaction behaviour of lactose-based coprocessed
excipients.
2. MATERIALS AND METHODS
2.1. Materials
Paracetamol (Acros Organics, Belgium) was
used as the model drug. Lactose monohydrate
(Carlo Erba Reagents, Italy) was used as filler
and glyceryl palmitostearate (Precirol® ATO 5
Gattefossé S.A.S, France) as meltable binder.
2.2. Preparation of co-processed excipients
Co-processed excipients were prepared by in
situ melt granulation in Mycrolab fluid bed
processor (OYSTAR Hüttlin, Germany).
Precirol® particles (15%) from the 125–180 μm
(≈ 150 μm) or 600–710 μm sieve fraction (≈ 655
μm) were used for granulation of lactose (85%).
The inlet air flow rate was 30 m3/h, and product
temperature during agglomeration was 65 °C.
2.3. Particle size and shape analysis
Granule size distribution was evaluated by sieve
analysis, and median particle diameter (d50) was
calculated by linear interpolation of the
cumulative percentage frequency curve.
Granule shape was examined by 2D scanned
image (4800 dpi resolution) analysis using
ImageJ software. The aspect ratio (AR) and
circularity (C) were calculated for granule shape
evaluation.
2.3. Determination of the Carr index
The bulk and tapped (1250 taps) densities of coprocessed
excipients and their mixtures with 30,
40 or 50% paracetamol were determined using
tap density tester STAV 2003 (J. Engelsmann
AG, Germany), and Carr index was calculated.
2.4. Dynamic compaction analysis
Co-processed excipients and their mixtures with
paracetamol were compressed on a single punch
instrumented tablet press (GTP D series,
Gamlen Tableting Ltd, UK). Compacts (100
mg) were compressed under compression load
of 200 kg (≈ 70 MPa) or 500 kg (≈ 173MPa),
and compression speed of 60 or 120 mm/min. 6
mm flat faced punches were used. The obtained
force-displacement curves were used to
calculate: net work of compression (NW),
detachment stress (DS), ejection stress (ES).
Tablet crushing force was determined using
tablet hardness tester Erweka TBH 125D
(Erweka GmbH, Germany), and the values
obtained were used to calculate tensile strength
(TS). Elastic recovery (24 h after compression)
was calculated, as well.
2.4. Experimental Design
In order to investigate the influence of binder
particle size, paracetamol content and
compression speed on the abovementioned
compaction properties, compacts were
prepared, at compression load of 500 kg,
according to 23 full factorial design.
3. RESULTS AND DISCUSSION
3.1. Particle size and shape
Larger initial binder particle size led to
formation of larger and more spherical granules
(Table 1).
147
Table 1. The size and shape of the co-processed
excipients’ particles.
Binder PS (μm) d50 AR C
150 564.9 1.33 0.81
655 846.2 1.14 0.86
3.2. Flowability
The Carr index values obtained indicated
considerably better flowability of the coprocessed
excipient prepared by using larger
binder particles (P655) in comparison with the
excipient prepared with smaller binder particles
(P150). This might be ascribed to more
spherical and larger particles of P655. However,
the addition of paracetamol led to an increase in
Carr index values and less pronounced
differences between two excipients (Fig. 1).
Figure 1. The influence of paracetamol loading
on flowability of co-processed excipients.
3.3. Compaction behaviour
The results obtained revealed better mechanical
properties of P150 in comparison with P655
compacts, irrespective of the compression
pressure applied. The addition of paracetamol,
as the model API with poor compaction
properties, led to decrease in tensile strength of
the compacts prepared with both excipients, and
paracetamol content showed statistically
significant influence on TS (p < 0.0001).
Acceptable tensile strength (> 1 MPa) could be
achieved for compacts with 30% paracetamol
compressed at higher compression pressure (≈
173 MPa).
Paracetamol content, compression speed and
interaction between binder particle size and
paracetamol content were found to significantly
affect NW. The influence of binder particle size
was more pronounced at higher paracetamol
content, with lower NW observed in the case of
P655. Higher compression speed led to higher
NW.
Relatively low values of detachment and
ejection stress (< 3.5 MPa) indicate good
antiadhesive and lubricating properties of the
investigated excipients. Lower values of both
parameters were observed in the case of P655
which could be related to different
agglomeration mechanisms involved. Besides
binder particle size, compression speed and
paracetamol content were found to significantly
influence these properties.
Elastic recovery values of the investigated
samples ranged between 12 and 28%. In the
case of both excipients, higher elastic recovery
values were obtained at higher compression
pressure. ER values of the compacts prepared at
higher compression pressure were significantly
affected by compression speed and interactions
of the investigated variables.
4. CONCLUSION
The results obtained show that meltable binder
particle size affects granule size and shape, and
consequently may influence flowability and
compaction behaviour of the co-processed
excipients. Interactions between binder particle
size and compaction variables were also found
to affect compaction properties of the
investigated excipients.",
publisher = "Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo",
journal = "9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts",
title = "Evaluation of dilution capacity and compaction behaviour of the excipients co-processed by in situ fluidized bed melt granulation",
pages = "146-147",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4735"
}
Aleksić, I., Ćirin-Varađan, S., Glišić, T., Đuriš, M., Đuriš, J.,& Parojčić, J.. (2022). Evaluation of dilution capacity and compaction behaviour of the excipients co-processed by in situ fluidized bed melt granulation. in 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts
Slovensko farmacevtsko društvo in Univerza v Ljubljani, Fakulteta za farmacijo., 146-147.
https://hdl.handle.net/21.15107/rcub_farfar_4735
Aleksić I, Ćirin-Varađan S, Glišić T, Đuriš M, Đuriš J, Parojčić J. Evaluation of dilution capacity and compaction behaviour of the excipients co-processed by in situ fluidized bed melt granulation. in 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts. 2022;:146-147.
https://hdl.handle.net/21.15107/rcub_farfar_4735 .
Aleksić, Ivana, Ćirin-Varađan, Slobodanka, Glišić, Teodora, Đuriš, Mihal, Đuriš, Jelena, Parojčić, Jelena, "Evaluation of dilution capacity and compaction behaviour of the excipients co-processed by in situ fluidized bed melt granulation" in 9th BBBB International Conference on Pharmaceutical Sciences Pharma Sciences of Tomorrow: Book of Abstracts (2022):146-147,
https://hdl.handle.net/21.15107/rcub_farfar_4735 .

An investigation into the influence of superdisintegrant type on properties of liquisolid systems with different carriers

Glišić, Teodora; Vasiljević, Ivana; Parojčić, Jelena; Aleksić, Ivana

(Savez farmaceutskih udruženja Srbije (SFUS), 2022)

TY  - CONF
AU  - Glišić, Teodora
AU  - Vasiljević, Ivana
AU  - Parojčić, Jelena
AU  - Aleksić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4570
AB  - Tablet disintegration in gastrointestinal fluids and the resulting increase in surface
area available for drug dissolution is one of the preconditions for achieving acceptable
bioavailability (1). Disintegrant addition shortens the disintegration time, but it can also
affect flowability and mechanical properties of liquisolid systems (2). The aim of this study
was to examine the influence of superdisintegrant type and concentration on flowability,
tensile strength and disintegration time of liquisolid systems prepared using three different
carriers.
The admixtures were prepared in a fluid bed processor. Syloid ® XDP3050, Neusilin®
US2 and Fujicalin ® were used as carriers, with liquid phase (macrogol 400) content of
40.4%, 54.8% and 14.8%, respectively, and carrier to coating material (colloidal silicon
dioxide) ratio R=30. Superdisintegrant (croscarmellose sodium, crospovidone, sodium starch
glycolate) concentration ranged from 2 to 5%. Admixtures’ flowability and compacts’ tensile
strength and disintegration time were determined. Admixtures with Fujicalin® showed the
best flowability. Superdisintegrant addition decreased flowability, except for Syloid®
XDP3050 admixtures where flowability improved with increase in disintegrant
concentration. Sodium starch glycolate had the most pronounced influence on the compact
tensile strength. Regardless of the carrier used, the increase in its concentration led to
decrease in tensile strength. Notable differences in the disintegration time were observed,
depending on the type of carrier and superdisintegrant. Compacts with Fujicalin®
disintegrated within the required time without the superdisintegrant addition. The shortest
disintegration time, for compacts with Syloid ® XDP3050 and Neusilin® US2, as well as the
highest tensile strength, for compacts with Syloid ® XDP3050, were achieved with
croscarmellose sodium.
AB  - Raspadanje tablete u kontaktu sa gastrointestinalnim tečnostima i posledično
povećanje površine dostupne za rastvaranje lekovite supstance jedan je od preduslova za
postizanje željene biološke raspoloživosti (1). Dodatak dezintegratora u tečno-čvrste
formulacije skraćuje vreme raspadanja, ali može uticati na protočna i mehanička svojstva
pripremljenih smeša, odnosno tableta (2). Cilj ovog istraživanja bio je ispitati uticaj vrste i
koncentracije tri tipa superdezintegratora na protočnost, zateznu čvrstinu i raspadljivost
tečno-čvrstih sistema pripremljenih upotrebom tri različita nosača. Smeše su pripremljene u
uređaju tipa fluidizirajućeg sistema. Syloid ® XDP3050, Neusilin® US2 i Fujicalin® su korišćeni
kao nosači, uz udeo tečne faze (makrogol 400) od 40,4%, 54,8% i 14,8%, redom, pri odnosu
nosača i sredstva za oblaganje (koloidni silicijum-dioksid) R=30. Udeo superdezintegratora
(kroskarmeloza-natrijum, krospovidon, natrijum-skrobglikolat) variran je u opsegu 2-5%.
Ispitana je protočnost, a nakon komprimovanja na ekscentar tablet mašini, kompaktima
određene zatezna čvrstina i raspadljivost. Najbolja protočnost primećena je kod smeša sa
Fujicalin®‐om. Dodatak superdezintegratora je snižavao protočnost, osim kod smeša sa
Syloid ® XDP3050 gde se povećanjem koncentracije superdezintegratora protočnost
poboljšavala. Najizraženiji uticaj na zateznu čvrstinu kompakata, bez obzira na vrstu nosača,
pokazao je natrijum-skrobglikolat. Povećanje udela ovog superdezintegratora dovelo je do
sniženja zatezne čvrstine kod ispitivanih kompakata. Uočene su znatne razlike u vremenu
raspadanja kompakata u zavisnosti od vrste nosača i superdezintegratora, a kompakti sa
Fujicalin®‐om su se raspadali za predviđeno vreme i bez dodatka superdezintegratora.
Kroskarmeloza-natrijum je superdezintegrator sa kojim je postignuto najkraće vreme
raspadanja tečno-čvrstih kompakata sa nosačima Syloid ® XDP3050 i Neusilin® US2, kao i
najveća zatezna čvrstina za kompakte sa Syloid ® XDP3050.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - An investigation into the influence of superdisintegrant type on properties of liquisolid systems with different carriers
T1  - Ispitivanje uticaja vrste superdezintegratora na svojstva tečno‐ čvrstih sistema sa različitim nosačima
VL  - 72
IS  - 4 suplement
SP  - S402
EP  - S403
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4570
ER  - 
@conference{
author = "Glišić, Teodora and Vasiljević, Ivana and Parojčić, Jelena and Aleksić, Ivana",
year = "2022",
abstract = "Tablet disintegration in gastrointestinal fluids and the resulting increase in surface
area available for drug dissolution is one of the preconditions for achieving acceptable
bioavailability (1). Disintegrant addition shortens the disintegration time, but it can also
affect flowability and mechanical properties of liquisolid systems (2). The aim of this study
was to examine the influence of superdisintegrant type and concentration on flowability,
tensile strength and disintegration time of liquisolid systems prepared using three different
carriers.
The admixtures were prepared in a fluid bed processor. Syloid ® XDP3050, Neusilin®
US2 and Fujicalin ® were used as carriers, with liquid phase (macrogol 400) content of
40.4%, 54.8% and 14.8%, respectively, and carrier to coating material (colloidal silicon
dioxide) ratio R=30. Superdisintegrant (croscarmellose sodium, crospovidone, sodium starch
glycolate) concentration ranged from 2 to 5%. Admixtures’ flowability and compacts’ tensile
strength and disintegration time were determined. Admixtures with Fujicalin® showed the
best flowability. Superdisintegrant addition decreased flowability, except for Syloid®
XDP3050 admixtures where flowability improved with increase in disintegrant
concentration. Sodium starch glycolate had the most pronounced influence on the compact
tensile strength. Regardless of the carrier used, the increase in its concentration led to
decrease in tensile strength. Notable differences in the disintegration time were observed,
depending on the type of carrier and superdisintegrant. Compacts with Fujicalin®
disintegrated within the required time without the superdisintegrant addition. The shortest
disintegration time, for compacts with Syloid ® XDP3050 and Neusilin® US2, as well as the
highest tensile strength, for compacts with Syloid ® XDP3050, were achieved with
croscarmellose sodium., Raspadanje tablete u kontaktu sa gastrointestinalnim tečnostima i posledično
povećanje površine dostupne za rastvaranje lekovite supstance jedan je od preduslova za
postizanje željene biološke raspoloživosti (1). Dodatak dezintegratora u tečno-čvrste
formulacije skraćuje vreme raspadanja, ali može uticati na protočna i mehanička svojstva
pripremljenih smeša, odnosno tableta (2). Cilj ovog istraživanja bio je ispitati uticaj vrste i
koncentracije tri tipa superdezintegratora na protočnost, zateznu čvrstinu i raspadljivost
tečno-čvrstih sistema pripremljenih upotrebom tri različita nosača. Smeše su pripremljene u
uređaju tipa fluidizirajućeg sistema. Syloid ® XDP3050, Neusilin® US2 i Fujicalin® su korišćeni
kao nosači, uz udeo tečne faze (makrogol 400) od 40,4%, 54,8% i 14,8%, redom, pri odnosu
nosača i sredstva za oblaganje (koloidni silicijum-dioksid) R=30. Udeo superdezintegratora
(kroskarmeloza-natrijum, krospovidon, natrijum-skrobglikolat) variran je u opsegu 2-5%.
Ispitana je protočnost, a nakon komprimovanja na ekscentar tablet mašini, kompaktima
određene zatezna čvrstina i raspadljivost. Najbolja protočnost primećena je kod smeša sa
Fujicalin®‐om. Dodatak superdezintegratora je snižavao protočnost, osim kod smeša sa
Syloid ® XDP3050 gde se povećanjem koncentracije superdezintegratora protočnost
poboljšavala. Najizraženiji uticaj na zateznu čvrstinu kompakata, bez obzira na vrstu nosača,
pokazao je natrijum-skrobglikolat. Povećanje udela ovog superdezintegratora dovelo je do
sniženja zatezne čvrstine kod ispitivanih kompakata. Uočene su znatne razlike u vremenu
raspadanja kompakata u zavisnosti od vrste nosača i superdezintegratora, a kompakti sa
Fujicalin®‐om su se raspadali za predviđeno vreme i bez dodatka superdezintegratora.
Kroskarmeloza-natrijum je superdezintegrator sa kojim je postignuto najkraće vreme
raspadanja tečno-čvrstih kompakata sa nosačima Syloid ® XDP3050 i Neusilin® US2, kao i
najveća zatezna čvrstina za kompakte sa Syloid ® XDP3050.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "An investigation into the influence of superdisintegrant type on properties of liquisolid systems with different carriers, Ispitivanje uticaja vrste superdezintegratora na svojstva tečno‐ čvrstih sistema sa različitim nosačima",
volume = "72",
number = "4 suplement",
pages = "S402-S403",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4570"
}
Glišić, T., Vasiljević, I., Parojčić, J.,& Aleksić, I.. (2022). An investigation into the influence of superdisintegrant type on properties of liquisolid systems with different carriers. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S402-S403.
https://hdl.handle.net/21.15107/rcub_farfar_4570
Glišić T, Vasiljević I, Parojčić J, Aleksić I. An investigation into the influence of superdisintegrant type on properties of liquisolid systems with different carriers. in Arhiv za farmaciju. 2022;72(4 suplement):S402-S403.
https://hdl.handle.net/21.15107/rcub_farfar_4570 .
Glišić, Teodora, Vasiljević, Ivana, Parojčić, Jelena, Aleksić, Ivana, "An investigation into the influence of superdisintegrant type on properties of liquisolid systems with different carriers" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S402-S403,
https://hdl.handle.net/21.15107/rcub_farfar_4570 .

Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives

Aleksić, Ivana; Glišić, Teodora; Parojčić, Jelena

(Pharmaceutical Association of Serbia, 2022)

TY  - JOUR
AU  - Aleksić, Ivana
AU  - Glišić, Teodora
AU  - Parojčić, Jelena
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4406
AB  - Liquisolid systems are a novel, promising platform for the production of solid dosage forms
with a high liquid content, i.e. dispersion of the drug in a suitable, hydrophilic, non-volatile liquid
vehicle or liquid drug. This technology requires conventional, but highly porous excipients
(carrier and coating material in the appropriate ratio) able to absorb/adsorb liquid medication,
resulting in both good flowability and acceptable compression properties. This approach has
shown great potential to improve the dissolution rate and bioavailability of poorly soluble drugs,
and has been recognized as a good alternative to common, more complex and expensive
techniques. A variety of applications of this simple technique have been investigated recently,
including the preparation of: modified release tablets, orally disintegrating tablets, solid dosage
forms with liquid herbal extracts, etc. This emerging technology has numerous advantages, and
the most important are: simplicity, cost-effectiveness, applicability in large scale production and
environmental friendliness. However, it is accompanied by certain challenges as well, such as
limited applicability in the case of highly dosed drugs. This article aims to give a comprehensive
overview of recent progress regarding the potential applications of this technology, as well as to
give an insight into the new liquisolid-based techniques intending to further support its
commercial applicability.
AB  - Tečno-čvrsti sistemi su nova, obećavajuća platforma za proizvodnju čvrstih farmaceutskih oblika sa visokim sadržajem tečnosti, odnosno disperzije lekovite supstance u pogodnom, hidrofilnom i neisparljivom tečnom vehikulumu ili same lekovite supstance u tečnom agregatnom stanju. Ova tehnologija podrazumeva upotrebu konvencionalnih, ali visoko poroznih ekscipijenasa (nosača i sredstva za oblaganje u odgovarajućem odnosu) koji mogu da absorbuju/adsorbuju tečnost uz zadržavanje dobre protočnosti i prihvatljivih svojstava pri kompresiji. Ovaj pristup je pokazao značajan potencijal da poboljša brzinu rastvaranja i bioraspoloživost slabo rastvorljivih lekovitih supstanci, a prepoznat je kao dobra alternativa uobičajeno primenjivanim, znatno složenijim i skupljim tehnikama. Pored toga, nedavno su istraživane brojne mogućnosti za primenu ove jednostavne tehnike, uključujući izradu: tableta sa modifikovanim oslobađanjem lekovite supstance, oralno disperzibilnih tableta, čvrstih farmaceutskih oblika sa tečnim biljnim ekstraktima, itd. Ova nova tehnologija pruža brojne prednosti, među kojima su najvažnije njena jednostavnost, ekonomičnost, primenljivost u industrijskoj proizvodnji i ekološka prihvatljivost. Međutim, prate je i izvesni izazovi, kao što je ograničena primenljivost u slučaju visoko doziranih lekovitih supstanci. Ovaj rad ima za cilj da pruži sveobuhvatan pregled nedavnog napretka u pogledu potencijalne primene ove tehnologije, kao i da pruži uvid u nove tehnike zasnovane na konceptu tečno-čvrstih sistema koje teže da dalje prošire njenu komercijalnu primenu.
PB  - Pharmaceutical Association of Serbia
T2  - Arhiv za farmaciju
T1  - Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives
T1  - Tečno-čvrsti sistemi kao novi pristup razvoju formulacija i proizvodnji čvrstih farmaceutskih oblika lekova - izazovi i perspektive
VL  - 72
IS  - 6
SP  - 521
EP  - 545
DO  - 10.5937/arhfarm72-40329
ER  - 
@article{
author = "Aleksić, Ivana and Glišić, Teodora and Parojčić, Jelena",
year = "2022",
abstract = "Liquisolid systems are a novel, promising platform for the production of solid dosage forms
with a high liquid content, i.e. dispersion of the drug in a suitable, hydrophilic, non-volatile liquid
vehicle or liquid drug. This technology requires conventional, but highly porous excipients
(carrier and coating material in the appropriate ratio) able to absorb/adsorb liquid medication,
resulting in both good flowability and acceptable compression properties. This approach has
shown great potential to improve the dissolution rate and bioavailability of poorly soluble drugs,
and has been recognized as a good alternative to common, more complex and expensive
techniques. A variety of applications of this simple technique have been investigated recently,
including the preparation of: modified release tablets, orally disintegrating tablets, solid dosage
forms with liquid herbal extracts, etc. This emerging technology has numerous advantages, and
the most important are: simplicity, cost-effectiveness, applicability in large scale production and
environmental friendliness. However, it is accompanied by certain challenges as well, such as
limited applicability in the case of highly dosed drugs. This article aims to give a comprehensive
overview of recent progress regarding the potential applications of this technology, as well as to
give an insight into the new liquisolid-based techniques intending to further support its
commercial applicability., Tečno-čvrsti sistemi su nova, obećavajuća platforma za proizvodnju čvrstih farmaceutskih oblika sa visokim sadržajem tečnosti, odnosno disperzije lekovite supstance u pogodnom, hidrofilnom i neisparljivom tečnom vehikulumu ili same lekovite supstance u tečnom agregatnom stanju. Ova tehnologija podrazumeva upotrebu konvencionalnih, ali visoko poroznih ekscipijenasa (nosača i sredstva za oblaganje u odgovarajućem odnosu) koji mogu da absorbuju/adsorbuju tečnost uz zadržavanje dobre protočnosti i prihvatljivih svojstava pri kompresiji. Ovaj pristup je pokazao značajan potencijal da poboljša brzinu rastvaranja i bioraspoloživost slabo rastvorljivih lekovitih supstanci, a prepoznat je kao dobra alternativa uobičajeno primenjivanim, znatno složenijim i skupljim tehnikama. Pored toga, nedavno su istraživane brojne mogućnosti za primenu ove jednostavne tehnike, uključujući izradu: tableta sa modifikovanim oslobađanjem lekovite supstance, oralno disperzibilnih tableta, čvrstih farmaceutskih oblika sa tečnim biljnim ekstraktima, itd. Ova nova tehnologija pruža brojne prednosti, među kojima su najvažnije njena jednostavnost, ekonomičnost, primenljivost u industrijskoj proizvodnji i ekološka prihvatljivost. Međutim, prate je i izvesni izazovi, kao što je ograničena primenljivost u slučaju visoko doziranih lekovitih supstanci. Ovaj rad ima za cilj da pruži sveobuhvatan pregled nedavnog napretka u pogledu potencijalne primene ove tehnologije, kao i da pruži uvid u nove tehnike zasnovane na konceptu tečno-čvrstih sistema koje teže da dalje prošire njenu komercijalnu primenu.",
publisher = "Pharmaceutical Association of Serbia",
journal = "Arhiv za farmaciju",
title = "Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives, Tečno-čvrsti sistemi kao novi pristup razvoju formulacija i proizvodnji čvrstih farmaceutskih oblika lekova - izazovi i perspektive",
volume = "72",
number = "6",
pages = "521-545",
doi = "10.5937/arhfarm72-40329"
}
Aleksić, I., Glišić, T.,& Parojčić, J.. (2022). Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives. in Arhiv za farmaciju
Pharmaceutical Association of Serbia., 72(6), 521-545.
https://doi.org/10.5937/arhfarm72-40329
Aleksić I, Glišić T, Parojčić J. Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives. in Arhiv za farmaciju. 2022;72(6):521-545.
doi:10.5937/arhfarm72-40329 .
Aleksić, Ivana, Glišić, Teodora, Parojčić, Jelena, "Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives" in Arhiv za farmaciju, 72, no. 6 (2022):521-545,
https://doi.org/10.5937/arhfarm72-40329 . .
1
1

Liquisolid systems: Evaluation of the influence of formulation variables on the optimum liquid load

Aleksić, Ivana; Glišić, Teodora; Cvijić, Sandra; Parojčić, Jelena

(Pharmaceutical Association of Serbia, 2022)

TY  - JOUR
AU  - Aleksić, Ivana
AU  - Glišić, Teodora
AU  - Cvijić, Sandra
AU  - Parojčić, Jelena
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4244
AB  - Liquisolid systems represent an emerging approach in the preparation of solid dosage forms with liquid lipophilic drug or poorly water-soluble drug solution/suspension in suitable liquid vehicle. This study addresses the lack of data regarding the compaction behavior of liquisolid systems, with the aim to investigate the influence of liquid load, carrier to coating ratio, carrier type (microcrystalline cellulose vs. spray dried calcium hydrogen phosphate, anhydrous (Fujicalin ® )) on flowability and compaction properties of liquisolid systems and to determine the optimum liquid loads. Liquisolid admixtures with Fujicalin® showed notably better flowability than those with microcrystalline cellulose. An increase in carrier to coating ratio led to enhanced flowability of the admixtures. Compacts with Fujicalin® had good mechanical properties up to 24.7% liquid, while those with microcrystalline cellulose had acceptable mechanical strength up to 16.2% liquid. Liquisolid systems with Fujicalin® showed similar tabletability profiles as those with microcrystalline cellulose, despite having higher liquid content. The ejection stress values indicated that the addition of lubricant might be needed in the case of liquisolid systems with Fujicalin ® . Superior properties of Fujicalin ® as a carrier for liquisolid tablets were revealed, and dynamic compaction analysis was found to be a valuable tool for the assessment of compaction behavior of liquisolid systems.
AB  - Tečno-čvrsti sistemi predstavljaju novi pristup izradi čvrstih farmaceutskih oblika koji sadrže tečnu lipofilnu lekovitu supstancu ili rastvor/suspenziju slabo rastvorljive lekovite supstance u pogodnom vehikulumu. Imajući u vidu nedostatak literaturnih podataka o ponašanju tečno-čvrstih sistema pri kompresiji, cilj ovog istraživanja je ispitivanje uticaja opterećenja tečnošću, odnosa nosača i sredstva za oblaganje, kao i vrste nosača (mikrokristalna celuloza i bezvodni kalcijum-hidrogenfosfat sušen raspršivanjem (Fujicalin ® )) na protočnost i svojstva tečno-čvrstih sistema pri kompresiji, kao i određivanje optimalnog opterećenja tečnošću. Tečno- čvrste smeše sa Fujicalin ® -om su pokazale znatno bolju protočnost nego smeše sa mikrokristalnom celulozom. Uočeno je da se sa povećanjem odnosa nosača i sredstva za oblaganje poboljšava protočnost smeša. Kompakti sa Fujicalin ® -om su imali dobra mehanička svojstva do udela od 24,7% tečnosti, a kompakti sa mikrokristalnom celulozom do udela od 16,2% tečnosti. Tečno-čvrsti sistemi sa Fujicalin ® -om su pokazali slične profile tabletabilnosti onim sa mikrokristalnom celulozom, uprkos tome što sadrže znatno veći udeo tečnosti. Vrednosti pritiska potrebnog za izbacivanje kompakta iz matrice ukazuju da bi dodatak lubrikansa mogao biti potreban u slučaju tečno-čvrstih sistema sa Fujicalin ® -om. Dobijeni rezultati ukazuju na superiorna svojstva Fujicalin ® -a kao nosača u tečno-čvrstim tabletama, a dinamička analiza kompakcije može predstavljati koristan alat za procenu ponašanja tečno-čvrstih sistema pri kompresiji.
PB  - Pharmaceutical Association of Serbia
T2  - Arhiv za farmaciju
T1  - Liquisolid systems: Evaluation of the influence of formulation variables on the optimum liquid load
T1  - Tečno-čvrsti sistemi: Ispitivanje uticaja faktora formulacije na optimalno opterećenje tečnošću
VL  - 72
IS  - 1
SP  - 61
EP  - 76
DO  - 10.5937/arhfarm72-33130
ER  - 
@article{
author = "Aleksić, Ivana and Glišić, Teodora and Cvijić, Sandra and Parojčić, Jelena",
year = "2022",
abstract = "Liquisolid systems represent an emerging approach in the preparation of solid dosage forms with liquid lipophilic drug or poorly water-soluble drug solution/suspension in suitable liquid vehicle. This study addresses the lack of data regarding the compaction behavior of liquisolid systems, with the aim to investigate the influence of liquid load, carrier to coating ratio, carrier type (microcrystalline cellulose vs. spray dried calcium hydrogen phosphate, anhydrous (Fujicalin ® )) on flowability and compaction properties of liquisolid systems and to determine the optimum liquid loads. Liquisolid admixtures with Fujicalin® showed notably better flowability than those with microcrystalline cellulose. An increase in carrier to coating ratio led to enhanced flowability of the admixtures. Compacts with Fujicalin® had good mechanical properties up to 24.7% liquid, while those with microcrystalline cellulose had acceptable mechanical strength up to 16.2% liquid. Liquisolid systems with Fujicalin® showed similar tabletability profiles as those with microcrystalline cellulose, despite having higher liquid content. The ejection stress values indicated that the addition of lubricant might be needed in the case of liquisolid systems with Fujicalin ® . Superior properties of Fujicalin ® as a carrier for liquisolid tablets were revealed, and dynamic compaction analysis was found to be a valuable tool for the assessment of compaction behavior of liquisolid systems., Tečno-čvrsti sistemi predstavljaju novi pristup izradi čvrstih farmaceutskih oblika koji sadrže tečnu lipofilnu lekovitu supstancu ili rastvor/suspenziju slabo rastvorljive lekovite supstance u pogodnom vehikulumu. Imajući u vidu nedostatak literaturnih podataka o ponašanju tečno-čvrstih sistema pri kompresiji, cilj ovog istraživanja je ispitivanje uticaja opterećenja tečnošću, odnosa nosača i sredstva za oblaganje, kao i vrste nosača (mikrokristalna celuloza i bezvodni kalcijum-hidrogenfosfat sušen raspršivanjem (Fujicalin ® )) na protočnost i svojstva tečno-čvrstih sistema pri kompresiji, kao i određivanje optimalnog opterećenja tečnošću. Tečno- čvrste smeše sa Fujicalin ® -om su pokazale znatno bolju protočnost nego smeše sa mikrokristalnom celulozom. Uočeno je da se sa povećanjem odnosa nosača i sredstva za oblaganje poboljšava protočnost smeša. Kompakti sa Fujicalin ® -om su imali dobra mehanička svojstva do udela od 24,7% tečnosti, a kompakti sa mikrokristalnom celulozom do udela od 16,2% tečnosti. Tečno-čvrsti sistemi sa Fujicalin ® -om su pokazali slične profile tabletabilnosti onim sa mikrokristalnom celulozom, uprkos tome što sadrže znatno veći udeo tečnosti. Vrednosti pritiska potrebnog za izbacivanje kompakta iz matrice ukazuju da bi dodatak lubrikansa mogao biti potreban u slučaju tečno-čvrstih sistema sa Fujicalin ® -om. Dobijeni rezultati ukazuju na superiorna svojstva Fujicalin ® -a kao nosača u tečno-čvrstim tabletama, a dinamička analiza kompakcije može predstavljati koristan alat za procenu ponašanja tečno-čvrstih sistema pri kompresiji.",
publisher = "Pharmaceutical Association of Serbia",
journal = "Arhiv za farmaciju",
title = "Liquisolid systems: Evaluation of the influence of formulation variables on the optimum liquid load, Tečno-čvrsti sistemi: Ispitivanje uticaja faktora formulacije na optimalno opterećenje tečnošću",
volume = "72",
number = "1",
pages = "61-76",
doi = "10.5937/arhfarm72-33130"
}
Aleksić, I., Glišić, T., Cvijić, S.,& Parojčić, J.. (2022). Liquisolid systems: Evaluation of the influence of formulation variables on the optimum liquid load. in Arhiv za farmaciju
Pharmaceutical Association of Serbia., 72(1), 61-76.
https://doi.org/10.5937/arhfarm72-33130
Aleksić I, Glišić T, Cvijić S, Parojčić J. Liquisolid systems: Evaluation of the influence of formulation variables on the optimum liquid load. in Arhiv za farmaciju. 2022;72(1):61-76.
doi:10.5937/arhfarm72-33130 .
Aleksić, Ivana, Glišić, Teodora, Cvijić, Sandra, Parojčić, Jelena, "Liquisolid systems: Evaluation of the influence of formulation variables on the optimum liquid load" in Arhiv za farmaciju, 72, no. 1 (2022):61-76,
https://doi.org/10.5937/arhfarm72-33130 . .
2
2

Dynamic compaction analysis of liquisolid systems with magnesium aluminometasilicate as carrier

Glišić, Teodora; Petrović, Jovana; Cvijić, Sandra; Parojčić, Jelena; Aleksić, Ivana

(Medical University of Gdansk, 2021)

TY  - CONF
AU  - Glišić, Teodora
AU  - Petrović, Jovana
AU  - Cvijić, Sandra
AU  - Parojčić, Jelena
AU  - Aleksić, Ivana
PY  - 2021
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5525
AB  - Development of novel porous excipients with high specific surface area enabled formulation of
liquisolid systems with considerably increased content of liquid drug (or drug solution/suspension)
in comparison to those prepared with commonly used carriers, such as microcrystalline cellulose,
while ensuring good flowability.  ...
PB  - Medical University of Gdansk
PB  - Polskie Towarzystwo Farmaceutyczne
C3  - Proceedings CESPT 2021: 13th Central European Symposium on Pharmaceutical Technology: Contemporary pharmaceutical technology - addressing challenges of innovative and generic medicinal products, 16th-18th September 2021, Gdansk, Poland
T1  - Dynamic compaction analysis of liquisolid systems with magnesium aluminometasilicate as carrier
SP  - 114
EP  - 115
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5525
ER  - 
@conference{
author = "Glišić, Teodora and Petrović, Jovana and Cvijić, Sandra and Parojčić, Jelena and Aleksić, Ivana",
year = "2021",
abstract = "Development of novel porous excipients with high specific surface area enabled formulation of
liquisolid systems with considerably increased content of liquid drug (or drug solution/suspension)
in comparison to those prepared with commonly used carriers, such as microcrystalline cellulose,
while ensuring good flowability.  ...",
publisher = "Medical University of Gdansk, Polskie Towarzystwo Farmaceutyczne",
journal = "Proceedings CESPT 2021: 13th Central European Symposium on Pharmaceutical Technology: Contemporary pharmaceutical technology - addressing challenges of innovative and generic medicinal products, 16th-18th September 2021, Gdansk, Poland",
title = "Dynamic compaction analysis of liquisolid systems with magnesium aluminometasilicate as carrier",
pages = "114-115",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5525"
}
Glišić, T., Petrović, J., Cvijić, S., Parojčić, J.,& Aleksić, I.. (2021). Dynamic compaction analysis of liquisolid systems with magnesium aluminometasilicate as carrier. in Proceedings CESPT 2021: 13th Central European Symposium on Pharmaceutical Technology: Contemporary pharmaceutical technology - addressing challenges of innovative and generic medicinal products, 16th-18th September 2021, Gdansk, Poland
Medical University of Gdansk., 114-115.
https://hdl.handle.net/21.15107/rcub_farfar_5525
Glišić T, Petrović J, Cvijić S, Parojčić J, Aleksić I. Dynamic compaction analysis of liquisolid systems with magnesium aluminometasilicate as carrier. in Proceedings CESPT 2021: 13th Central European Symposium on Pharmaceutical Technology: Contemporary pharmaceutical technology - addressing challenges of innovative and generic medicinal products, 16th-18th September 2021, Gdansk, Poland. 2021;:114-115.
https://hdl.handle.net/21.15107/rcub_farfar_5525 .
Glišić, Teodora, Petrović, Jovana, Cvijić, Sandra, Parojčić, Jelena, Aleksić, Ivana, "Dynamic compaction analysis of liquisolid systems with magnesium aluminometasilicate as carrier" in Proceedings CESPT 2021: 13th Central European Symposium on Pharmaceutical Technology: Contemporary pharmaceutical technology - addressing challenges of innovative and generic medicinal products, 16th-18th September 2021, Gdansk, Poland (2021):114-115,
https://hdl.handle.net/21.15107/rcub_farfar_5525 .

Liquisolid systems with mesoporous silica based carriers: An investigation of flow and compaction properties

Aleksić, Ivana; Vasiljević, Ivana; Glišić, Teodora; Cvijić, Sandra; Parojčić, Jelena

(International Association for Pharmaceutical Technology, Mainz, Germany, 2021)

TY  - CONF
AU  - Aleksić, Ivana
AU  - Vasiljević, Ivana
AU  - Glišić, Teodora
AU  - Cvijić, Sandra
AU  - Parojčić, Jelena
PY  - 2021
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5316
AB  - Liquisolid technology has gained an increased attention as a
promising approach for the improvement of bioavailability
of poorly water soluble drugs. Suitable excipients with high
surface area and porous structure are used to convert liquid
lipophilic drugs or drug solutions/suspensions to powder
suitable for filling into capsules or compression into tablets.
Spireas (1) proposed this approach and pointed out the
importance of selecting the appropriate excipients (carrier
and coating material) in optimum amounts in order to
achieve both good flowability and acceptable compaction
properties, as prerequisites for industrial application.
Compaction properties of liquisolid systems have been
recognized as particularly challenging. However, the
published results regarding compression behavior of
liquisolid systems are still very limited (2, 3).
In the present study mesoporous, amorphous silica
excipients (Syloid® XDP 3050 and XDP 3150), optimized
to be used as carriers in liquisolid systems, were used for
preparation of liquisolid compacts. The aim of this study
was to evaluate the influence of carrier to coating ratio and
liquid content on flowability and compaction behavior of
liquisolid systems prepared with these novel excipients.
PB  - International Association for Pharmaceutical Technology, Mainz, Germany
C3  - 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11th-14th May 2021, Vienna, Austria, Virtual meeting
T1  - Liquisolid systems with mesoporous silica based carriers: An investigation of flow and compaction properties
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5316
ER  - 
@conference{
author = "Aleksić, Ivana and Vasiljević, Ivana and Glišić, Teodora and Cvijić, Sandra and Parojčić, Jelena",
year = "2021",
abstract = "Liquisolid technology has gained an increased attention as a
promising approach for the improvement of bioavailability
of poorly water soluble drugs. Suitable excipients with high
surface area and porous structure are used to convert liquid
lipophilic drugs or drug solutions/suspensions to powder
suitable for filling into capsules or compression into tablets.
Spireas (1) proposed this approach and pointed out the
importance of selecting the appropriate excipients (carrier
and coating material) in optimum amounts in order to
achieve both good flowability and acceptable compaction
properties, as prerequisites for industrial application.
Compaction properties of liquisolid systems have been
recognized as particularly challenging. However, the
published results regarding compression behavior of
liquisolid systems are still very limited (2, 3).
In the present study mesoporous, amorphous silica
excipients (Syloid® XDP 3050 and XDP 3150), optimized
to be used as carriers in liquisolid systems, were used for
preparation of liquisolid compacts. The aim of this study
was to evaluate the influence of carrier to coating ratio and
liquid content on flowability and compaction behavior of
liquisolid systems prepared with these novel excipients.",
publisher = "International Association for Pharmaceutical Technology, Mainz, Germany",
journal = "12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11th-14th May 2021, Vienna, Austria, Virtual meeting",
title = "Liquisolid systems with mesoporous silica based carriers: An investigation of flow and compaction properties",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5316"
}
Aleksić, I., Vasiljević, I., Glišić, T., Cvijić, S.,& Parojčić, J.. (2021). Liquisolid systems with mesoporous silica based carriers: An investigation of flow and compaction properties. in 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11th-14th May 2021, Vienna, Austria, Virtual meeting
International Association for Pharmaceutical Technology, Mainz, Germany..
https://hdl.handle.net/21.15107/rcub_farfar_5316
Aleksić I, Vasiljević I, Glišić T, Cvijić S, Parojčić J. Liquisolid systems with mesoporous silica based carriers: An investigation of flow and compaction properties. in 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11th-14th May 2021, Vienna, Austria, Virtual meeting. 2021;.
https://hdl.handle.net/21.15107/rcub_farfar_5316 .
Aleksić, Ivana, Vasiljević, Ivana, Glišić, Teodora, Cvijić, Sandra, Parojčić, Jelena, "Liquisolid systems with mesoporous silica based carriers: An investigation of flow and compaction properties" in 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11th-14th May 2021, Vienna, Austria, Virtual meeting (2021),
https://hdl.handle.net/21.15107/rcub_farfar_5316 .

Investigation into the influence of carrier type on characteristics of liquisolid compacts prepared with natural active principles

Glišić, Teodora; Vlatković, Milica; Boričić, Anica; Bjelobrk, Jelena; Parojčić, Jelena; Aleksić, Ivana

(Savez farmaceutskih udruženja Srbije (SFUS), 2021)

TY  - CONF
AU  - Glišić, Teodora
AU  - Vlatković, Milica
AU  - Boričić, Anica
AU  - Bjelobrk, Jelena
AU  - Parojčić, Jelena
AU  - Aleksić, Ivana
PY  - 2021
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4672
AB  - The use of herbal preparations and preparations based on bee products is
increasingly present in modern therapy, but the number of solid dosage forms with these
active principles present on the market is relatively small (1). Liquisolid systems are
formulations where liquid medication is converted into powder with good flowability,
compressibility and compactibility, using selected excipients. This simple and energy
efficient process could find application in the production of solid dosage forms with liquid
extracts, which would contribute to overcoming some of the challenges associated with the
use of these preparations, such as imprecise dosing, unpleasant taste and ease of application
for patients (2). The aim of this study was to examine the influence of carrier type on
flowability, tabletability, disintegration and wettability of liquisolid compacts prepared with
natural liquid extracts.
Syloid ® XDP 3050, Neusilin® US2, Fujicalin® and Vivapur® type 101 were used as
carriers, and colloidal silicon dioxide as a coating agent. St. John's wort oil extract and
propylene glycol extract of propolis were used as the liquid phase. The admixtures were
prepared using mortar and pestle, concentration of liquid phase ranged between 15.4% and
49.8%. Flowability was examined by three different methods. Compaction properties were
tested after compression on an eccentric tablet machine and compaction analyser.
Disintegration time and wetting properties were investigated, as well.
The admixtures containing St. John's wort oil extract showed good flowability
regardless of the carrier used. Admixtures containing propolis extract showed fair
flowability, except the admixture with Neusilin ® US2 as a carrier which, despite the high
liquid load, showed good flowability. Acceptable tensile strength was achieved in all
compacts compressed using compaction analyser. The influence of formulation factors (type
of carrier, type and concentration of liquid phase) on wettability of liquisolid compacts was
observed. The shortest wetting time was achieved with microcrystalline cellulose, in
compacts with St. John's wort oil extract, and Fujicalin® , in compacts with propylene glycol
extract of propolis, respectively. In both cases, the highest water absorption ratio was
achieved with microcrystalline cellulose as a carrier. Liquisolid compacts with propylene
glycol extract of propolis and Fujicalin® showed satisfactory disintegration time, while the
addition of a superdisintegrant would be necessary for all the other formulations.
The obtained results indicate a significant potential for the application of highly
porous carriers and liquisolid technology as an approach to convert liquid preparations with
natural active principles into tablets, a dosage form widely accepted by patients.
AB  - Primena biljnih preparata i preparata na bazi pčelinjih proizvoda sve je više
zastupljena u savremenoj terapiji, ali je na tržištu prisutan mali broj čvrstih farmaceutskih
oblika sa ovim aktivnim principima (1). Tečno-čvrsti sistemi (engl. liquisolid systems)
predstavljaju formulacije kod kojih se primenom odabranih ekscipijenasa aktivna supstanca
u tečnom obliku ili njen rastvor/disperzija prevodi u prašak dobre protočnosti,
kompresibilnosti i kompaktibilnosti. Ovaj jednostavan i energetski efikasan postupak bi
mogao naći primenu u proizvodnji čvrstih farmaceutskih oblika sa tečnim ekstraktima, što bi
doprinelo prevazilaženju nekih od izazova povezanih sa primenom ovih preparata kao što su
neprecizno doziranje, neprijatan ukus i jednostavnost primene za pacijente (2). Cilj ovog
rada bio je da se ispita uticaj vrste nosača na protočnost, tabletabilnost, raspadljivost i
sposobnost kvašenja tečno-čvrstih kompakata pripremljenih sa tečnim ekstraktima
prirodnog porekla.
Porozni ekscipijensi Syloid® XDP 3050, Neusilin® US2, Fujicalin® i Vivapur ® type 101
korišćeni su kao nosači, a koloidni silicijum-dioksid kao sredstvo za oblaganje. Kao tečna faza
korišćeni su biljni preparat na bazi uljanog ekstrakta kantariona i propilenglikolni ekstrakt
propolisa. Smeše su pripremljene pomoću tarionika i pistila, udeo tečne faze kretao se od
15,4% до 49,8%. Protočnost pripremljenih smeša ispitana je primenom tri različite metode.
Svojstva pri kompresiji ispitana su nakon komprimovanja na ekscentar tablet mašini i
simulatoru kompakcije, a zatim su ispitane raspadljivost i sposobnost kvašenja kompakata.
Sve smeše pripremljene sa uljanim ekstraktom kantariona pokazale su dobru
protočnost nezavisno od primenjenog nosača. Smeše pripremljene sa ekstraktom propolisa
pokazale su umerenu protočnost, osim smeše sa Neusilin® US2 kao nosačem koja je i pored
visokog udela tečne faze pokazala dobru protočnost. Zadovoljavajuća zatezna čvrstina
postignuta je kod svih kompakata izrađenih na simulatoru kompakcije. Uočen je uticaj
faktora formulacije (vrsta nosača, vrsta i udeo tečne faze) na sposobnost kvašenja tečno-
čvrstih kompakata. Najkraće vreme kvašenja postignuto je kada je kao nosač korišćena
mikrokristalna celuloza, kod kompakata sa uljanim ekstraktom kantariona, odnosno
Fujicalin® , kod kompakata sa propilenglikolnim ekstraktom propolisa. U oba slučaja najveći
stepen apsorpcije vode postignut je sa mikrokristalnom celulozom kao nosačem.
Ispitivanjem raspadljivosti utvrđeno je da tečno-čvrsti kompakti sa propilenglikolnim
ekstraktom propolisa i Fujicalin®-om kao nosačem pokazuju zadovoljavajuću raspadljivost,
dok je za sve druge formulacije neophodan dodatak superdezintegratora.
Dobijeni rezultati ukazuju na značajan potencijal primene visoko poroznih nosača i
tehnologije tečno-čvrstih sistema kao pristupa za prevođenje tečnih preparata sa aktivnim
principima prirodnog porekla u tablete, kao farmaceutski oblik koji je široko prihvaćen od
strane pacijenata.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Investigation into the influence of carrier type on characteristics of liquisolid compacts prepared with natural active principles
T1  - Ispitivanje uticaja vrste nosača na svojstva tečno‐čvrstih kompakata sa aktivnim principima prirodnog porekla
VL  - 71
IS  - 5 suplement
SP  - S82
EP  - S85
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4672
ER  - 
@conference{
author = "Glišić, Teodora and Vlatković, Milica and Boričić, Anica and Bjelobrk, Jelena and Parojčić, Jelena and Aleksić, Ivana",
year = "2021",
abstract = "The use of herbal preparations and preparations based on bee products is
increasingly present in modern therapy, but the number of solid dosage forms with these
active principles present on the market is relatively small (1). Liquisolid systems are
formulations where liquid medication is converted into powder with good flowability,
compressibility and compactibility, using selected excipients. This simple and energy
efficient process could find application in the production of solid dosage forms with liquid
extracts, which would contribute to overcoming some of the challenges associated with the
use of these preparations, such as imprecise dosing, unpleasant taste and ease of application
for patients (2). The aim of this study was to examine the influence of carrier type on
flowability, tabletability, disintegration and wettability of liquisolid compacts prepared with
natural liquid extracts.
Syloid ® XDP 3050, Neusilin® US2, Fujicalin® and Vivapur® type 101 were used as
carriers, and colloidal silicon dioxide as a coating agent. St. John's wort oil extract and
propylene glycol extract of propolis were used as the liquid phase. The admixtures were
prepared using mortar and pestle, concentration of liquid phase ranged between 15.4% and
49.8%. Flowability was examined by three different methods. Compaction properties were
tested after compression on an eccentric tablet machine and compaction analyser.
Disintegration time and wetting properties were investigated, as well.
The admixtures containing St. John's wort oil extract showed good flowability
regardless of the carrier used. Admixtures containing propolis extract showed fair
flowability, except the admixture with Neusilin ® US2 as a carrier which, despite the high
liquid load, showed good flowability. Acceptable tensile strength was achieved in all
compacts compressed using compaction analyser. The influence of formulation factors (type
of carrier, type and concentration of liquid phase) on wettability of liquisolid compacts was
observed. The shortest wetting time was achieved with microcrystalline cellulose, in
compacts with St. John's wort oil extract, and Fujicalin® , in compacts with propylene glycol
extract of propolis, respectively. In both cases, the highest water absorption ratio was
achieved with microcrystalline cellulose as a carrier. Liquisolid compacts with propylene
glycol extract of propolis and Fujicalin® showed satisfactory disintegration time, while the
addition of a superdisintegrant would be necessary for all the other formulations.
The obtained results indicate a significant potential for the application of highly
porous carriers and liquisolid technology as an approach to convert liquid preparations with
natural active principles into tablets, a dosage form widely accepted by patients., Primena biljnih preparata i preparata na bazi pčelinjih proizvoda sve je više
zastupljena u savremenoj terapiji, ali je na tržištu prisutan mali broj čvrstih farmaceutskih
oblika sa ovim aktivnim principima (1). Tečno-čvrsti sistemi (engl. liquisolid systems)
predstavljaju formulacije kod kojih se primenom odabranih ekscipijenasa aktivna supstanca
u tečnom obliku ili njen rastvor/disperzija prevodi u prašak dobre protočnosti,
kompresibilnosti i kompaktibilnosti. Ovaj jednostavan i energetski efikasan postupak bi
mogao naći primenu u proizvodnji čvrstih farmaceutskih oblika sa tečnim ekstraktima, što bi
doprinelo prevazilaženju nekih od izazova povezanih sa primenom ovih preparata kao što su
neprecizno doziranje, neprijatan ukus i jednostavnost primene za pacijente (2). Cilj ovog
rada bio je da se ispita uticaj vrste nosača na protočnost, tabletabilnost, raspadljivost i
sposobnost kvašenja tečno-čvrstih kompakata pripremljenih sa tečnim ekstraktima
prirodnog porekla.
Porozni ekscipijensi Syloid® XDP 3050, Neusilin® US2, Fujicalin® i Vivapur ® type 101
korišćeni su kao nosači, a koloidni silicijum-dioksid kao sredstvo za oblaganje. Kao tečna faza
korišćeni su biljni preparat na bazi uljanog ekstrakta kantariona i propilenglikolni ekstrakt
propolisa. Smeše su pripremljene pomoću tarionika i pistila, udeo tečne faze kretao se od
15,4% до 49,8%. Protočnost pripremljenih smeša ispitana je primenom tri različite metode.
Svojstva pri kompresiji ispitana su nakon komprimovanja na ekscentar tablet mašini i
simulatoru kompakcije, a zatim su ispitane raspadljivost i sposobnost kvašenja kompakata.
Sve smeše pripremljene sa uljanim ekstraktom kantariona pokazale su dobru
protočnost nezavisno od primenjenog nosača. Smeše pripremljene sa ekstraktom propolisa
pokazale su umerenu protočnost, osim smeše sa Neusilin® US2 kao nosačem koja je i pored
visokog udela tečne faze pokazala dobru protočnost. Zadovoljavajuća zatezna čvrstina
postignuta je kod svih kompakata izrađenih na simulatoru kompakcije. Uočen je uticaj
faktora formulacije (vrsta nosača, vrsta i udeo tečne faze) na sposobnost kvašenja tečno-
čvrstih kompakata. Najkraće vreme kvašenja postignuto je kada je kao nosač korišćena
mikrokristalna celuloza, kod kompakata sa uljanim ekstraktom kantariona, odnosno
Fujicalin® , kod kompakata sa propilenglikolnim ekstraktom propolisa. U oba slučaja najveći
stepen apsorpcije vode postignut je sa mikrokristalnom celulozom kao nosačem.
Ispitivanjem raspadljivosti utvrđeno je da tečno-čvrsti kompakti sa propilenglikolnim
ekstraktom propolisa i Fujicalin®-om kao nosačem pokazuju zadovoljavajuću raspadljivost,
dok je za sve druge formulacije neophodan dodatak superdezintegratora.
Dobijeni rezultati ukazuju na značajan potencijal primene visoko poroznih nosača i
tehnologije tečno-čvrstih sistema kao pristupa za prevođenje tečnih preparata sa aktivnim
principima prirodnog porekla u tablete, kao farmaceutski oblik koji je široko prihvaćen od
strane pacijenata.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Investigation into the influence of carrier type on characteristics of liquisolid compacts prepared with natural active principles, Ispitivanje uticaja vrste nosača na svojstva tečno‐čvrstih kompakata sa aktivnim principima prirodnog porekla",
volume = "71",
number = "5 suplement",
pages = "S82-S85",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4672"
}
Glišić, T., Vlatković, M., Boričić, A., Bjelobrk, J., Parojčić, J.,& Aleksić, I.. (2021). Investigation into the influence of carrier type on characteristics of liquisolid compacts prepared with natural active principles. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 71(5 suplement), S82-S85.
https://hdl.handle.net/21.15107/rcub_farfar_4672
Glišić T, Vlatković M, Boričić A, Bjelobrk J, Parojčić J, Aleksić I. Investigation into the influence of carrier type on characteristics of liquisolid compacts prepared with natural active principles. in Arhiv za farmaciju. 2021;71(5 suplement):S82-S85.
https://hdl.handle.net/21.15107/rcub_farfar_4672 .
Glišić, Teodora, Vlatković, Milica, Boričić, Anica, Bjelobrk, Jelena, Parojčić, Jelena, Aleksić, Ivana, "Investigation into the influence of carrier type on characteristics of liquisolid compacts prepared with natural active principles" in Arhiv za farmaciju, 71, no. 5 suplement (2021):S82-S85,
https://hdl.handle.net/21.15107/rcub_farfar_4672 .